Ketamine has spent the past decade moving from an anesthesia drug with a reputation problem to the subject of hundreds of published studies on depression, trauma, and psychological healing. The latest phase of that shift is not about the drug alone. It is about pairing it with structured psychotherapy, an approach known as ketamine-assisted psychotherapy, or KAP, that psychiatrists say changes what the medication can actually do for a patient.
What Makes KAP Different From a Standard Infusion
A standard ketamine infusion is a medical procedure. A patient receives the drug, usually by IV or intramuscular injection, and is monitored until the effects wear off. KAP adds a therapeutic layer around that same medical foundation. Sessions are typically built around three phases: preparation, where a therapist helps a patient set intentions and understand what to expect; the dosing session itself, often with a therapist present in the room; and integration, follow-up sessions where the patient and therapist work through what came up during the experience.
The reasoning behind the model is grounded in what ketamine does to the brain in the hours after dosing. At sub-anesthetic doses, the drug appears to temporarily reduce defensive psychological processing, which some clinicians describe as loosening rigid thought patterns just enough to let a patient engage with difficult material, whether that is trauma, grief, or entrenched negative beliefs, with more openness than usual. A therapist in the room, or in the sessions immediately after, is there to help make sense of what surfaces rather than leaving a patient to process it alone.
Who Tends to Benefit
Psychiatrists presenting on the model at recent American Psychiatric Association meetings have been consistent on one point: KAP is not meant to replace standard ketamine infusions or established first-line treatments. It is framed as a complementary option, best suited to patients who have already tried conventional therapy and medication without enough relief, or whose psychological rigidity makes it hard to engage with talk therapy alone.
Most of the research base still centers on depression, particularly treatment-resistant depression, but a growing number of studies are examining KAP for anxiety, PTSD, and obsessive-compulsive disorder. The Johns Hopkins Psychiatry Guide describes KAP as a heterogeneous practice, noting that it is not yet clear whether the therapeutic benefit comes primarily from ketamine's biological activity at glutamate receptors, the dissociative experience itself, or some combination of the two working alongside concurrent therapy.
What a Course of Treatment Actually Looks Like
For patients considering KAP, the practical experience is different from a quick in-and-out medical appointment. Preparation sessions happen before any dosing, giving a patient and therapist time to build rapport and talk through goals. The dosing sessions themselves can run an hour or more, often in a quiet, low-stimulation room designed to support an inward-focused experience rather than a clinical one. Understanding what actually happens during a ketamine infusion session, from the setting to the monitoring, tends to ease a lot of the uncertainty patients bring to their first appointment.
Integration sessions, which happen in the days following a dosing session, are where much of the psychological work takes place. Therapists help patients connect what came up during the experience to their daily lives, relationships, and existing patterns, rather than treating the dosing session itself as the endpoint of treatment.
A Model That Is Still Being Defined
KAP is not standardized the way a medication dose is. Protocols vary by provider in terms of session length, dosing route, and how much therapeutic support happens during versus after the dosing period, and clinics differ in training and philosophy. That variability is part of why researchers describe the field as still developing consensus on best practices, even as clinical interest accelerates.
Programs built around the KAP model, including Village TMS's ketamine-assisted psychotherapy program, generally emphasize that screening and therapist involvement throughout the process, not just the ketamine itself, are what shape outcomes. For patients who have not found relief through medication and talk therapy alone, that combination is increasingly being framed as worth a closer look.
Screening and Safety Considerations
Because ketamine-assisted psychotherapy still involves administering a controlled substance, candidates go through a medical and psychiatric evaluation before starting, covering cardiovascular history, current medications, and any history of substance misuse. Ketamine can raise blood pressure and heart rate temporarily, so patients with certain cardiovascular conditions may need additional clearance or may not be appropriate candidates at all.
The psychological screening matters just as much. Therapists generally want to understand a patient's history and current stability before introducing an experience that can surface difficult material quickly. For patients with certain untreated psychotic symptoms, the altered perceptual state ketamine produces can be counterproductive rather than helpful, which is part of why intake typically involves both a psychiatrist and a therapist rather than one or the other alone.
Side effects during a session tend to be short-lived: temporary dissociation, mild nausea, or a floating sensation that resolves within an hour or two as the drug clears the system. Because of that temporary altered state, patients are asked to arrange a ride home and to avoid driving or operating machinery for the rest of the day.
The growing research interest in ketamine-assisted psychotherapy reflects a broader shift in psychiatry toward treatments that pair a biological intervention with structured psychological support, rather than treating the two as separate tracks. Whether that combination becomes standard practice or remains a specialized option will depend largely on how the next few years of research shape up.
This article is for general informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified health provider with questions about a medical condition.
